Digest Network Come funziona
Network
/
Società
Ev
Non verificato

Evaxion

Di cosa scriviamo

Annunci EconomiciBiotecnologiaFinanzaPubblicità/Marketing/Media/Comunicazione

20 comunicati stampa

Guarda tutti i comunicati
06/12/2025
Biotecnologia
Annunci Economici
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
20/11/2025
Biotecnologia
Annunci Economici
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
12/11/2025
Biotecnologia
Annunci Economici
Evaxion announce 2026 financial calendar
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
07/11/2025
Biotecnologia
Annunci Economici
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
06/11/2025
Biotecnologia
Annunci Economici
Evaxion announces business update and third quarter 2025 financial results
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
03/11/2025
Biotecnologia
Annunci Economici
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
31/10/2025
Biotecnologia
Annunci Economici
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
31/10/2025
Biotecnologia
Annunci Economici
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
30/10/2025
Biotecnologia
Annunci Economici
Evaxion raises $7.2 million, extending cash runway to second half of 2027
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0
27/10/2025
Biotecnologia
Annunci Economici
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
Fonte
Evaxion
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0